Women’s evaluation of pain during insertion2*
Women experienced:
18.5%
no pain
(268/1452)
47.0%
mild pain
(638/1452)
27.5%
moderate pain
(400/1452)
6.9%
severe pain
(100/1452)
Almost two thirds (65.5%) of women in the study experienced no pain or mild pain.
There was a trend towards less pain in parous women compared to nulliparous women.2
* Results from a multi-centre international, open-label, randomized clinical study for 3 years with an extension to 5 years in 1,452 women aged 18–35 evaluating the contraceptive efficacy of KYLEENA® (levonorgestrel-releasing intrauterine system [19.5 mg]).
